Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Degron Partners Molecular Glue Degraders with Takeda in $1.2 Billion Deal

Nona Bio Signs $604 Million License to Discover mAbs for AstraZeneca

BeiGene Forms India Distribution Partnership with Mumbai’s Glenmark

Hengrui Sells GLP-1 Portfolio Rights to Startup in $6 Billion Deal

Erasca In-licenses Two China RAS Candidates in Two Deals Worth $349 Million

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital